Suppr超能文献

基于人群的肺癌队列中直接手术质量反馈前后的生存情况。

Survival Before and After Direct Surgical Quality Feedback in a Population-Based Lung Cancer Cohort.

机构信息

Division of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, University of Memphis, Memphis, Tennessee.

Multidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, Tennessee.

出版信息

Ann Thorac Surg. 2019 May;107(5):1487-1493. doi: 10.1016/j.athoracsur.2018.11.058. Epub 2018 Dec 27.

Abstract

BACKGROUND

Surgical resection is the main curative modality for non-small cell lung cancer (NSCLC), but variation in the quality of care contributes to suboptimal survival rates. Improving surgical outcomes by eliminating quality deficits is a key strategy for improving population-level lung cancer survival. We evaluated the long-term survival effect of providing direct feedback on institutional performance in a population-based cohort.

METHODS

The Mid-South Quality of Surgical Resection cohort includes all NSCLC resections at 11 hospitals in four contiguous Dartmouth Hospital Referral Regions in Arkansas, Mississippi, and Tennessee. We evaluated resections from 2004 to 2013, before and after onset of a benchmarked performance feedback campaign to surgery and pathology teams in 2009.

RESULTS

We evaluated 2,206 patients: 56% preintervention (pre-era) and 44% postintervention (post-era). Preoperative positron emission tomography/computed tomography (46% vs 82%, p < 0.0001), brain scans (6% vs 21%, p < 0.0001), and bronchoscopy (8% vs 27%, p < 0.0001) were more frequently used in the post-era. Patients had 5-year survival of 47% (44% to 50%) in the pre-era compared with 53% (50% to 56%) in the post-era (p = 0.0028). The post-era had an adjusted hazard ratio of 0.85 (95% confidence interval [CI], 0.75 to 0.97; p = 0.0158) compared with the pre-era. This differed by extent of resection (p = 0.0113): compared with the pre-era, the post-era adjusted hazard ratio was 0.49 (95% CI, 0.33 to 0.72) in pneumonectomy, 0.91 (95% CI, 0.79 to 1.05) in lobectomy/bilobectomy, and 0.85 (95% CI, 0.63 to 1.15) in segmentectomy/wedge resections.

CONCLUSIONS

Overall survival after surgical resection improved significantly in a high lung cancer mortality region of the United States. Reasons may include better selection of patients for pneumonectomy and more thorough staging.

摘要

背景

手术切除是非小细胞肺癌(NSCLC)的主要治疗方法,但治疗质量的差异导致生存率不理想。通过消除质量缺陷来提高手术效果是提高人群肺癌生存率的关键策略。我们评估了在人群队列中提供机构绩效直接反馈对长期生存的影响。

方法

中南部手术切除质量队列包括阿肯色州、密西西比州和田纳西州四个达特茅斯医院转诊区 11 家医院的所有 NSCLC 切除术。我们评估了 2004 年至 2013 年的切除术,在此之前和之后,2009 年对手术和病理团队进行了基准绩效反馈活动。

结果

我们评估了 2206 名患者:56%为干预前(前时代),44%为干预后(后时代)。干预后,正电子发射断层扫描/计算机断层扫描(46%比 82%,p<0.0001)、脑部扫描(6%比 21%,p<0.0001)和支气管镜检查(8%比 27%,p<0.0001)的使用率更高。在前时代,患者的 5 年生存率为 47%(44%至 50%),在后时代为 53%(50%至 56%)(p=0.0028)。与前时代相比,后时代的调整后的危险比为 0.85(95%置信区间[CI],0.75 至 0.97;p=0.0158)。这因切除范围而异(p=0.0113):与前时代相比,在后时代,肺切除术的调整后的危险比为 0.49(95%CI,0.33 至 0.72),肺叶切除术/双叶切除术为 0.91(95%CI,0.79 至 1.05),节段切除术/楔形切除术为 0.85(95%CI,0.63 至 1.15)。

结论

在美国一个肺癌死亡率较高的地区,手术后的总体生存率显著提高。原因可能包括对肺切除术患者的更好选择和更彻底的分期。

相似文献

1
Survival Before and After Direct Surgical Quality Feedback in a Population-Based Lung Cancer Cohort.
Ann Thorac Surg. 2019 May;107(5):1487-1493. doi: 10.1016/j.athoracsur.2018.11.058. Epub 2018 Dec 27.
2
Evolution in the Surgical Care of Patients With Non-Small Cell Lung Cancer in the Mid-South Quality of Surgical Resection Cohort.
Semin Thorac Cardiovasc Surg. 2017;29(1):91-101. doi: 10.1053/j.semtcvs.2016.10.001. Epub 2016 Oct 14.
3
Outcomes of lobar and sublobar resections for non-small-cell lung cancer: a single-center experience.
South Med J. 2015 Apr;108(4):230-4. doi: 10.14423/SMJ.0000000000000272.
5
Prognostic Value of National Comprehensive Cancer Network Lung Cancer Resection Quality Criteria.
Ann Thorac Surg. 2017 May;103(5):1557-1565. doi: 10.1016/j.athoracsur.2017.01.098. Epub 2017 Mar 31.
6
Survival Rates After Lobectomy, Segmentectomy, and Wedge Resection for Non-Small Cell Lung Cancer.
Ann Thorac Surg. 2018 May;105(5):1483-1491. doi: 10.1016/j.athoracsur.2018.01.032. Epub 2018 Feb 17.
7
Should males ever undergo wedge resection for stage 1 non-small-cell lung cancer? A propensity analysis.
Eur J Cardiothorac Surg. 2014 Aug;46(2):267-73; discussion 273. doi: 10.1093/ejcts/ezt603. Epub 2014 Jan 12.
8
Long-Term Results for Clinical Stage IA Lung Cancer: Comparing Lobectomy and Sublobar Resection.
Ann Thorac Surg. 2018 Aug;106(2):375-381. doi: 10.1016/j.athoracsur.2018.02.049. Epub 2018 Mar 23.
10
Long-term outcomes of surgical resection for stage IV non-small-cell lung cancer: A national analysis.
Lung Cancer. 2018 Jan;115:75-83. doi: 10.1016/j.lungcan.2017.11.021. Epub 2017 Nov 23.

引用本文的文献

本文引用的文献

1
Effectiveness of Implemented Interventions on Pathologic Nodal Staging of Non-Small Cell Lung Cancer.
Ann Thorac Surg. 2018 Jul;106(1):228-234. doi: 10.1016/j.athoracsur.2018.02.021. Epub 2018 Mar 11.
2
Cancer statistics, 2018.
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
5
Evolution in the Surgical Care of Patients With Non-Small Cell Lung Cancer in the Mid-South Quality of Surgical Resection Cohort.
Semin Thorac Cardiovasc Surg. 2017;29(1):91-101. doi: 10.1053/j.semtcvs.2016.10.001. Epub 2016 Oct 14.
6
Survival impact of postoperative therapy modalities according to margin status in non-small cell lung cancer patients in the United States.
J Thorac Cardiovasc Surg. 2017 Aug;154(2):661-672.e10. doi: 10.1016/j.jtcvs.2017.03.085. Epub 2017 Apr 4.
7
Treatment of stage I non-small cell lung cancer: What's trending?
J Thorac Cardiovasc Surg. 2017 Sep;154(3):1080-1087. doi: 10.1016/j.jtcvs.2017.03.122. Epub 2017 Apr 5.
9
Prognostic Value of National Comprehensive Cancer Network Lung Cancer Resection Quality Criteria.
Ann Thorac Surg. 2017 May;103(5):1557-1565. doi: 10.1016/j.athoracsur.2017.01.098. Epub 2017 Mar 31.
10
Lung Cancer Screening With Low-Dose Computed Tomography in the United States-2010 to 2015.
JAMA Oncol. 2017 Sep 1;3(9):1278-1281. doi: 10.1001/jamaoncol.2016.6416.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验